Antibody-drug conjugates—an emerging class of cancer treatment
Crossref DOI link: https://doi.org/10.1038/bjc.2015.435
Published Online: 2016-01-07
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Diamantis, Nikolaos
Banerji, Udai
Text and Data Mining valid from 2016-01-07
Article History
Received: 14 July 2015
Revised: 16 October 2015
Accepted: 26 October 2015
First Online: 7 January 2016
Competing interests
: The authors declare no conflict of interest.